Evidence map›Paper›PMID 32941977›Full record

ArticleJournal of virological methods2020

Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2.

Abu Naser Mohon, Lisa Oberding, Jana Hundt, Guido van Marle, Kanti Pabbaraju, Byron M Berenger, Luiz Lisboa, Thomas Griener, Markus Czub, Cody Doolan and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Abu Naser MohonDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada.
Lisa OberdingDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada.
Jana HundtDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Guido van MarleDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada.
Kanti PabbarajuAlberta Public Health Laboratory, Alberta Precision Laboratory, Calgary, AB, Canada.
Byron M BerengerAlberta Public Health Laboratory, Alberta Precision Laboratory, Calgary, AB, Canada; Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada.
Luiz LisboaClinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada; Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.
Thomas GrienerClinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada; Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.
Markus CzubFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Cody DoolanIllucidx Inc., Calgary, AB, Canada.
Venice ServellitaDepartment Pathology and Laboratory Medicine, University of California, San Francisco, USA.
Charles Y ChiuDepartment Pathology and Laboratory Medicine, University of California, San Francisco, USA.
Alexander L GreningerDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Keith R JeromeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Dylan R PillaiDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada; Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada; Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada; Department of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: drpillai@ucalgary.ca.
University of Calgary · CACalgary Laboratory Services · CAUniversity of California, San Francisco · USFred Hutch Cancer Center · USUniversity of Washington · US

Funding

Canadian Institutes for Health Research
6 · The paper itself

Abstract

A novel reverse-transcriptase loop mediated amplification (RT-LAMP) method targeting genes encoding the Spike (S) protein and RNA-dependent RNA polymerase (RdRP) of SARS-CoV-2 has been developed. The LAMP assay achieves a comparable limit of detection (25-50 copies per reaction) to commonly used RT-PCR protocols using clinical samples quantified by digital droplet PCR. Precision, cross-reactivity, inclusivity, and limit of detection studies were performed according to regulatory standards. Clinical validation of dual-target RT-LAMP (S and RdRP gene) achieved a PPA of 98.48 % (95 % CI 91.84%-99.96%) and NPA 100.00 % (95 % CI 93.84%-100.00%) based on the E gene and N2 gene reference RT-PCR methods. The method has implications for development of point of care technology using isothermal amplification.

Indexed as

BetacoronavirusClinical Laboratory TechniquesComputer SimulationCoronavirus Envelope ProteinsCoronavirus InfectionsCOVID-19COVID-19 TestingHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesPandemicsPneumonia, ViralPoint-of-Care SystemsRNA-Directed DNA PolymeraseRNA, ViralSARS-CoV-2Coronavirus Envelope Proteinsenvelope protein, SARS-CoV-2RNA-Directed DNA PolymeraseRNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral Envelope ProteinsAssayCovidDiagnosticsLAMPMolecularPCRSARS-CoV-2Validation

Identifiers

PMID32941977
PMCPMC7490281
OpenAlexW3085854736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.